The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate)
- PMID: 2104082
- DOI: 10.1111/j.1365-2036.1990.tb00461.x
The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate)
Abstract
Plasma bismuth and plasma salicylate concentrations were measured before and after three 30-ml oral doses of bismuth salicylate (Pepto-Bismol liquid) in 10 fasting healthy subjects. From 0 to 120 min following the first dose of bismuth salicylate, the plasma bismuth concentration was less than 1 ng/ml. The peak median plasma bismuth concentration was at +240 min (1.7 ng/ml; range 0.8-5.3 ng/ml). Salicylate appeared in the plasma of all subjects at +30 min, and it reached a peak at +120 min (median 61 mg/L; range 46-104 mg/L). The study demonstrates that, despite rapid and substantial absorption of salicylate, there is negligible absorption of bismuth into the bloodstream from standard oral doses of bismuth salicylate.
Similar articles
-
Salicylate absorption from a bismuth subsalicylate preparation.Clin Pharmacol Ther. 1981 Jun;29(6):788-92. doi: 10.1038/clpt.1981.112. Clin Pharmacol Ther. 1981. PMID: 7226711
-
Bismuth subsalicylate: history, chemistry, and safety.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S3-8. doi: 10.1093/clinids/12.supplement_1.s3. Rev Infect Dis. 1990. PMID: 2406853 Review.
-
The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.Gastroenterology. 1991 Oct;101(4):889-94. doi: 10.1016/0016-5085(91)90712-t. Gastroenterology. 1991. PMID: 1889712 Clinical Trial.
-
Pepto-bismol and salicylate levels.Mayo Clin Proc. 1989 Jan;64(1):129. doi: 10.1016/s0025-6196(12)65315-4. Mayo Clin Proc. 1989. PMID: 2911212 No abstract available.
-
Bismuth Subsalicylate.2024 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Sep 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000383 Free Books & Documents. Review.
Cited by
-
D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.Br J Clin Pharmacol. 1990 Oct;30(4):648-50. doi: 10.1111/j.1365-2125.1990.tb03829.x. Br J Clin Pharmacol. 1990. PMID: 2291879 Free PMC article.
-
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).Eur J Clin Pharmacol. 1994;47(2):177-80. doi: 10.1007/BF00194969. Eur J Clin Pharmacol. 1994. PMID: 7859806 Clinical Trial.
-
Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.Sci Rep. 2021 Jan 28;11(1):2605. doi: 10.1038/s41598-021-82044-3. Sci Rep. 2021. PMID: 33510326 Free PMC article.
-
The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.Adv Ther. 2021 May;38(5):2054-2076. doi: 10.1007/s12325-021-01676-z. Epub 2021 Mar 18. Adv Ther. 2021. PMID: 33738725 Free PMC article. Review.
-
Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.Mol Neurobiol. 1998 Winter;17(1-3):109-35. doi: 10.1007/BF02802027. Mol Neurobiol. 1998. PMID: 9887449 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources